Investment Rating - The investment rating for the company is "Buy" with a target price of HKD 1.90, reflecting a valuation premium due to its leading position in the industry and expected profit elasticity under the dual-cycle resonance [5][4]. Core Insights - The company is positioned as a core leader in the upstream dairy industry, with a clear and steadily improving cyclical evolution path. It is expected to be at the bottom of the industry cycle in 2025, with marginal recovery in beef prices and low raw milk prices. The apparent profit losses are gradually narrowing, showcasing cash profit resilience [1][5]. - In 2026, the company is anticipated to enter a phase of cyclical recovery, with a gradual initiation of dairy and meat resonance. This is expected to lead to volume and price recovery, impairment improvement, and potential merger synergies, collectively enhancing performance elasticity [3][1]. - The peak of the dual-cycle resonance for dairy and meat is projected to occur in 2028, establishing a "stable dairy and strong meat" pattern, with a solid foundation for profitability and significant profit elasticity expected to be released [3][1]. Summary by Sections 2025 Review - In the first half of 2025, the company achieved revenue of RMB 6.07 billion, a year-on-year decrease of 5.4%. The raw milk business revenue was RMB 5.07 billion, down 0.8% year-on-year. Despite the decline in raw milk prices, the company leveraged its industry-leading annual yield to effectively counteract price drop pressures [10]. - The net profit attributable to the parent company for the first half of 2025 was a loss of RMB 980 million, primarily due to weak raw milk prices leading to significant non-cash losses from fair value changes in biological assets [10]. 2026 Outlook - Under a neutral assumption, it is expected that raw milk supply and demand will be in a tight balance in 2026, with milk prices stabilizing and beef prices continuing to rise. The acquisition of China Shengmu is anticipated to be completed in 2026, leading to profit improvement [3][10]. - The company is expected to achieve a mid-single-digit growth in raw milk business revenue in 2026, benefiting from the downward trend in feed costs and steady yield improvements. If the acquisition proceeds smoothly, the herd size will increase from 470,000 to over 610,000, further enhancing scale effects and synergy [10][3]. Profit Forecast and Valuation - The profit forecast has been adjusted upwards, with expected EPS for 2025, 2026, and 2027 at RMB -0.14, RMB 0.09, and RMB 0.17 respectively, reflecting increases of 14% for both 2025 and 2026, and 22% for 2027 [4]. - The estimated tax-pre profit increment from the meat and dairy cycle reversal from 2025 to 2028 is approximately RMB 3.1 billion [3].
现代牧业（01117）：双周期演进路径清晰且盈利弹性可期